BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10363650)

  • 1. Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism.
    Hasselgren PO
    Mol Biol Rep; 1999 Apr; 26(1-2):71-6. PubMed ID: 10363650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways.
    Voisin L; Breuillé D; Combaret L; Pouyet C; Taillandier D; Aurousseau E; Obled C; Attaix D
    J Clin Invest; 1996 Apr; 97(7):1610-7. PubMed ID: 8601625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways of muscle protein breakdown in injury and sepsis.
    Hasselgren PO
    Curr Opin Clin Nutr Metab Care; 1999 Mar; 2(2):155-60. PubMed ID: 10453347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions.
    Hasselgren PO; Fischer JE
    Ann Surg; 1997 Mar; 225(3):307-16. PubMed ID: 9060588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle.
    Wray CJ; Sun X; Gang GI; Hasselgren PO
    J Surg Res; 2002 May; 104(2):82-7. PubMed ID: 12020124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis.
    Hobler SC; Williams A; Fischer D; Wang JJ; Sun X; Fischer JE; Monaco JJ; Hasselgren PO
    Am J Physiol; 1999 Aug; 277(2):R434-40. PubMed ID: 10444550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors.
    Hobler SC; Tiao G; Fischer JE; Monaco J; Hasselgren PO
    Am J Physiol; 1998 Jan; 274(1):R30-7. PubMed ID: 9458895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle.
    Tiao G; Hobler S; Wang JJ; Meyer TA; Luchette FA; Fischer JE; Hasselgren PO
    J Clin Invest; 1997 Jan; 99(2):163-8. PubMed ID: 9005983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats.
    Lecker SH; Solomon V; Price SR; Kwon YT; Mitch WE; Goldberg AL
    J Clin Invest; 1999 Nov; 104(10):1411-20. PubMed ID: 10562303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts.
    Solomon V; Goldberg AL
    J Biol Chem; 1996 Oct; 271(43):26690-7. PubMed ID: 8900146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
    Jagoe RT; Goldberg AL
    Curr Opin Clin Nutr Metab Care; 2001 May; 4(3):183-90. PubMed ID: 11517350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-proteasome-dependent proteolysis in skeletal muscle.
    Attaix D; Aurousseau E; Combaret L; Kee A; Larbaud D; Rallière C; Souweine B; Taillandier D; Tilignac T
    Reprod Nutr Dev; 1998; 38(2):153-65. PubMed ID: 9638789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The balance between glucocorticoids and insulin regulates muscle proteolysis via the ubiquitin-proteasome pathway.
    Bailey JL; Wang X; Price SR
    Miner Electrolyte Metab; 1999; 25(4-6):220-3. PubMed ID: 10681643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.
    Attaix D; Combaret L; Tilignac T; Taillandier D
    Mol Biol Rep; 1999 Apr; 26(1-2):77-82. PubMed ID: 10363651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats.
    Combaret L; Tilignac T; Claustre A; Voisin L; Taillandier D; Obled C; Tanaka K; Attaix D
    Biochem J; 2002 Jan; 361(Pt 2):185-92. PubMed ID: 11772390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting.
    Mitch WE; Bailey JL; Wang X; Jurkovitz C; Newby D; Price SR
    Am J Physiol; 1999 May; 276(5):C1132-8. PubMed ID: 10329962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway.
    Bailey JL; Wang X; England BK; Price SR; Ding X; Mitch WE
    J Clin Invest; 1996 Mar; 97(6):1447-53. PubMed ID: 8617877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
    Liu Z; Miers WR; Wei L; Barrett EJ
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation.
    Hasselgren PO; Fischer JE
    Ann Surg; 2001 Jan; 233(1):9-17. PubMed ID: 11141219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma.
    Baracos VE; DeVivo C; Hoyle DH; Goldberg AL
    Am J Physiol; 1995 May; 268(5 Pt 1):E996-1006. PubMed ID: 7539218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.